Development and Validation of a Prediction Model for Co-Occurring Moderate-to-Severe Anxiety Symptoms in First-Episode and Drug Naïve Patients With Major Depressive Disorder
- PMID: 40226721
- PMCID: PMC11922193
- DOI: 10.1155/da/9950256
Development and Validation of a Prediction Model for Co-Occurring Moderate-to-Severe Anxiety Symptoms in First-Episode and Drug Naïve Patients With Major Depressive Disorder
Abstract
Background: Moderate-to-severe anxiety symptoms are severe and common in patients with major depressive disorder (MDD) and have a significant impact on MDD patients and their families. The main objective of this study was to develop a risk prediction model for moderate-to-severe anxiety in MDD patients to make the detection more accurate and effective. Methods: We conducted a cross-sectional survey and tested biochemical indicators in 1718 first-episode and drug naïve (FEDN) patients with MDD. Using machine learning, we developed a risk prediction model for moderate-to-severe anxiety in these FEDN patients with MDD. Results: Four predictors were identified from a total of 21 variables studied by least absolute shrinkage and selection operator (LASSO) regression analysis, namely psychotic symptoms, suicide attempts, thyroid stimulating hormone (TSH), and Hamilton Depression Scale (HAMD) total score. The model built from the four predictors showed good predictive power, with an area under the receiver operating characteristic (ROC) curve of 0.903 for the training set and 0.896 for the validation set. The decision curve analysis (DCA) curve indicated that the nomogram could be applied to clinical practice if the risk thresholds were between 13% and 40%. In the external validation, the risk threshold was between 14% and 40%. Conclusion: The inclusion of psychotic symptoms, suicide attempts, TSH, and HAMD in the risk nomogram may improve its utility in identifying patients with MDD at risk of moderate-to-severe anxiety. It may be helpful in clinical decision-making or for conferring with patients, especially in risk-based interventions.
Copyright © da Xiao Huang and Xiang-Yang Zhang.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures






Similar articles
-
Prevalence and clinical profiles of comorbid anxiety in first episode and drug naïve patients with major depressive disorder.J Affect Disord. 2019 Oct 1;257:200-206. doi: 10.1016/j.jad.2019.06.052. Epub 2019 Jul 2. J Affect Disord. 2019. PMID: 31301624
-
The incidence and influencing factors of recent suicide attempts in major depressive disorder patients comorbid with moderate-to-severe anxiety: a large-scale cross-sectional study.BMC Psychiatry. 2025 Jan 9;25(1):31. doi: 10.1186/s12888-025-06472-5. BMC Psychiatry. 2025. PMID: 39789491 Free PMC article.
-
Establishment of a risk prediction model for suicide attempts in first-episode and drug naïve patients with major depressive disorder.Asian J Psychiatr. 2023 Oct;88:103732. doi: 10.1016/j.ajp.2023.103732. Epub 2023 Aug 11. Asian J Psychiatr. 2023. PMID: 37586124
-
Prevalence and clinical profile of comorbid anxiety in young adult patients with first-episode and drug-naive major depressive disorder.Early Interv Psychiatry. 2024 Jun;18(6):406-414. doi: 10.1111/eip.13478. Epub 2023 Nov 27. Early Interv Psychiatry. 2024. PMID: 38011857
-
Clinical correlates, lipid metabolic parameters and thyroid hormones are associated with abnormal glucose metabolism in first-episode and drug-naïve major depressive disorder patients with suicide attempts: A large cross-sectional study.J Affect Disord. 2025 Jul 1;380:10-16. doi: 10.1016/j.jad.2025.03.102. Epub 2025 Mar 20. J Affect Disord. 2025. PMID: 40120949
References
-
- Merikangas K. R., He J.-P., Burstein M., et al. Lifetime Prevalence of Mental Disorders in U.S. Adolescents: Results From the National Comorbidity Survey Replication–Adolescent Supplement (NCS-A) Journal of the American Academy of Child & Adolescent Psychiatry . 2010;49(10):980–989. doi: 10.1016/j.jaac.2010.05.017. - DOI - PMC - PubMed
-
- Kessler R. C., Petukhova M., Sampson N. A., Zaslavsky A. M., Wittchen H.-U. Twelve-Month and Lifetime Prevalence and Lifetime Morbid Risk of Anxiety and Mood Disorders in the United States. International Journal of Methods In Psychiatric Research . 2012;21(3):169–184. doi: 10.1002/mpr.1359. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical